10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ELI LILLY & CO | ||
Ticker: LLY Fiscal Year: 2021 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2021 10-K (Filed: Feb 23, 2022) | ||
| (In Thousands, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2021 | Dec 31, 2020 | |
| Assets | ||
| Current Assets | ||
| Cash and cash equivalents (Note 7) | $ 3,818,500 | 3,657,100 |
| Short-term investments (Note 7) | 90,100 | 24,200 |
| Accounts receivable, net of allowances of $22.5 (2021) and $25.9 (2020) | 6,672,800 | 5,875,300 |
| Other receivables | 1,454,400 | 1,053,700 |
| Inventories (Note 6) | 3,886,000 | 3,980,300 |
| Prepaid expenses and other | 2,530,600 | 2,871,500 |
| Total current assets | 18,452,400 | 17,462,100 |
| Investments (Note 7) | 3,212,600 | 2,966,800 |
| Goodwill (Note 8) | 3,892,000 | 3,766,500 |
| Other intangibles, net (Note 8) | 7,691,900 | 7,450,000 |
| Deferred tax assets (Note 14) | 2,489,300 | 2,830,400 |
| Property and equipment, net (Note 9) | 8,985,100 | 8,681,900 |
| Other noncurrent assets | 4,082,700 | 3,475,400 |
| Total assets | 48,806,000 | 46,633,100 |
| Liabilities and Equity | ||
| Current Liabilities | ||
| Short-term borrowings and current maturities of long-term debt (Note 11) | 1,538,300 | 8,700 |
| Accounts payable | 1,670,600 | 1,606,700 |
| Employee compensation | 958,100 | 997,200 |
| Sales rebates and discounts | 6,845,800 | 5,853,000 |
| Dividends payable | 885,500 | 770,600 |
| Income taxes payable (Note 14) | 126,900 | 495,100 |
| Other current liabilities | 3,027,500 | 2,750,300 |
| Total current liabilities | 15,052,700 | 12,481,600 |
| Other Liabilities | ||
| Long-term debt (Note 11) | 15,346,400 | 16,586,600 |
| Accrued retirement benefits (Note 15) | 1,954,100 | 4,094,500 |
| Long-term income taxes payable (Note 14) | 3,920,000 | 3,837,800 |
| Deferred tax liabilities (Note 14) | 1,733,700 | 2,099,900 |
| Other noncurrent liabilities | 1,644,300 | 1,707,500 |
| Total other liabilities | 24,598,500 | 28,326,300 |
| Commitments and Contingencies (Note 16) | ||
| Eli Lilly and Company Shareholders' Equity (Notes 12 and 13) | ||
| Common stockno par value Authorized shares: 3,200,000 Issued shares: 954,116 (2021) and 957,077 (2020) | 596,300 | 598,200 |
| Additional paid-in capital | 6,833,400 | 6,778,500 |
| Retained earnings | 8,958,500 | 7,830,200 |
| Employee benefit trust | (3,013,200) | (3,013,200) |
| Accumulated other comprehensive loss (Note 17) | (4,343,100) | (6,496,400) |
| Cost of common stock in treasury | (52,700) | (55,700) |
| Total Eli Lilly and Company shareholders' equity | 8,979,200 | 5,641,600 |
| Noncontrolling interests | 175,600 | 183,600 |
| Total equity | 9,154,800 | 5,825,200 |
| Total liabilities and equity | 48,806,000 | 46,633,100 |
| External Links | |
| ELI LILLY & CO (LLY) Fiscal Year 2021 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |